ARNP, Kenneth Kavanagh, ARNP (Co-Investigators) Clinical Trial U01 HD040497-06 NIH, Patricia Emmanuel, MD Pediatric Infectious ATN is a national, multicenter research Adolescent Trials Network (PI), Diane Straub, MD, , Diseases network, to conduct research to explore MD, , MD, Jorge Lujan, behavioral, microbicidal, prophylactic, MD, Alicia Marion, ARNP, therapeutic, and vaccine modalities in Kenneth Kavanagh, ARNP and HIV at-risk adolescents, age 12 (Co-Investigators) through 24 Clinical Trial Changes in the B cell repertoire , (PI), , MD, , PhD, Pediatric Infectious Immunologic responses to H1N1 inactivated following vaccination with novel Maureen Goodenow, PhD Diseases, Allergy influenza vaccine in HIV-infected adolescents H1N1 inactivated influenza and Immunology and young adults vaccine in immune deficient (USF) and Pathology adolescents and young adults (UF) chronically infected with HIV Clinical Trial Treatment De-intensification Allergy and Effects of early treatment followed by and Residual HIV-1 in Youth. Immunology, USF treatment deintensification. Sponsor: NICHD (ATN 081) Clinical Trial Preservation & Expansion of Allergy and Early treatment of HIV during deintensification Subsets Following HAART Immunology, USF to ATV/r. De-intensification to Sponsor: NICHD Atazanavir/ritonavir (ATN 061) Clinical Trial Longitudinal changes in Allergy and Cardiovascular risks in HIV-infected cardiovascular risk markers Immunology, USF adolescents. among adolescents newly Sponsor: NICHD infected with HIV (ATN 083) Clinical Trial Assessment of inflammatory Allergy and Neurocognitive impairment in HIV. Markets Associated with Immunology, USF Sponsor: NICHD Neurocognitive impairment in HIV-infected Adolescents (ATN 101) Clinical Trial A randomized placebo Allergy and LPS levels and immunity preservation. trial of probiotics to Immunology, USF Sponsor: NICHD lower microbial translocation & immune activation in
ARNP, Kenneth Kavanagh, ARNP (Co-Investigators) Clinical Trial U01 HD040497-06 NIH, Adolescent Trials Network Patricia Emmanuel, MD (PI), Diane Straub, MD, , MD, , MD, Jorge Lujan, MD, Alicia Marion, ARNP, Kenneth Kavanagh, ARNP (Co-Investigators) Pediatric Infectious Diseases ATN is a national, multicenter research network, to conduct research to explore behavioral, microbicidal, prophylactic, therapeutic, and vaccine modalities in and HIV at-risk adolescents, age 12 through 24 Clinical Trial Changes in the B cell repertoire following vaccination with novel H1N1 inactivated influenza vaccine in immune deficient adolescents and young adults chronically infected with HIV , (PI), , MD, , PhD, Maureen Goodenow, PhD Pediatric Infectious Diseases, Allergy and Immunology (USF) and Pathology (UF) Immunologic responses to H1N1 inactivated influenza vaccine in HIV-infected adolescents and young adults Clinical Trial Treatment De-intensification and Residual HIV-1 in Youth. (ATN 081) Allergy and Immunology, USF Effects of early treatment followed by treatment deintensification. Sponsor: NICHD Clinical Trial Preservation & Expansion of Subsets Following HAART De-intensification to Atazanavir/ritonavir (ATN 061) Allergy and Immunology, USF Early treatment of HIV during deintensification to ATV/r. Sponsor: NICHD Clinical Trial Longitudinal changes in cardiovascular risk markers among adolescents newly infected with HIV (ATN 083) Allergy and Immunology, USF Cardiovascular risks in HIV-infected adolescents. Sponsor: NICHD Clinical Trial Assessment of inflammatory Markets Associated with Neurocognitive impairment in HIV-infected Adolescents (ATN 101) Allergy and Immunology, USF Neurocognitive impairment in HIV. Sponsor: NICHD Clinical Trial A randomized placebo trial of probiotics to lower microbial translocation & immune activation in Allergy and Immunology, USF LPS levels and immunity preservation. Sponsor: NICHD
12-31-12%20FCHAR%20Inventory.docx